Sally C. Pipes

Commentary

Kamala Harris’s harrowing healthcare history

Sen. Kamala Harris will be the Democratic Party’s nominee for vice president, we learned on Tuesday. The pick appears to be in line with former Vice President Joe Biden’s semi-moderate instincts. But on healthcare, Harris has proved anything but moderate. She has a long track record of support for government-run healthcare. ...
Commentary

Another coronavirus lockdown would hurt these patients and providers

Last week, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci urged states with rising COVID-19 rates to consider a new round of lockdown restrictions. “You may need to pause, you may need to drop back a little bit,” Fauci said. “I don’t think you necessarily have to revert to go all the way ...
Commentary

Dems use coronavirus to push ‘Medicare-for-all,’ but their ploy is based on bad information

More than 5 million Americans have lost their employer-sponsored health insurance due to coronavirus-related unemployment, according to a new study from FamiliesUSA. In response, Democrats are renewing their push for “Medicare-for-all”. Just this week, 360 Democratic delegates promised to vote against any party platform that doesn’t endorse single-payer health care. In their formal petition, ...
Commentary

COVID-19 makes routine vaccinations more important

As Americans eagerly anticipate a COVID-19 vaccine, there’s troubling new evidence that they’re failing to get inoculated against other infectious diseases. To get vaccination rates back where they need to be, policymakers must remind the public of the importance of routine immunizations and remove the regulatory barriers that make it ...
Commentary

Mourning The Many Foibles Of Medicare And Medicaid At 55

Today, Medicare and Medicaid both mark their 55th birthdays. But hold the cake. There’s not much to celebrate on this anniversary. You’d be hard pressed to find two more wasteful, fraud-ridden programs than Medicare and Medicaid. They grow less fiscally sustainable with each passing year. And they routinely deliver subpar care that, ...
Commentary

Affordable short-term healthcare plans can flourish thanks to Trump

Millions of people will continue to have access to affordable short-term health plans, thanks to a new ruling from the U.S. District Court of Appeals for the District of Columbia. A three-judge panel of the court upheld by a 2-1 margin a Trump administration rule extending the maximum duration of a short-term plan to ...
Commentary

After COVID-19 subsides, ‘the telehealth revolution must march on’

It’s hard to find a silver lining in a pandemic. But one of the few may be the rapid rise of telemedicine. With people stuck at home, doctors retooled their practices to see patients via videoconference. Insurance companies and regulators expanded the number of services available via telemedicine—and made reimbursement ...
Business & Economics

It’s time to bring our economy back to life. Paying workers to stay home won’t help

The federal government’s emergency unemployment benefits are set to expire this week. Set at $600 a week by the CARES Act — the economic rescue package Congress passed back in March — the emergency benefits were intended to supplement state unemployment insurance and offset the economic carnage caused by the coronavirus lockdowns. That extra ...
Commentary

Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs

President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Drug Pricing

Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing

Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Commentary

Kamala Harris’s harrowing healthcare history

Sen. Kamala Harris will be the Democratic Party’s nominee for vice president, we learned on Tuesday. The pick appears to be in line with former Vice President Joe Biden’s semi-moderate instincts. But on healthcare, Harris has proved anything but moderate. She has a long track record of support for government-run healthcare. ...
Commentary

Another coronavirus lockdown would hurt these patients and providers

Last week, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci urged states with rising COVID-19 rates to consider a new round of lockdown restrictions. “You may need to pause, you may need to drop back a little bit,” Fauci said. “I don’t think you necessarily have to revert to go all the way ...
Commentary

Dems use coronavirus to push ‘Medicare-for-all,’ but their ploy is based on bad information

More than 5 million Americans have lost their employer-sponsored health insurance due to coronavirus-related unemployment, according to a new study from FamiliesUSA. In response, Democrats are renewing their push for “Medicare-for-all”. Just this week, 360 Democratic delegates promised to vote against any party platform that doesn’t endorse single-payer health care. In their formal petition, ...
Commentary

COVID-19 makes routine vaccinations more important

As Americans eagerly anticipate a COVID-19 vaccine, there’s troubling new evidence that they’re failing to get inoculated against other infectious diseases. To get vaccination rates back where they need to be, policymakers must remind the public of the importance of routine immunizations and remove the regulatory barriers that make it ...
Commentary

Mourning The Many Foibles Of Medicare And Medicaid At 55

Today, Medicare and Medicaid both mark their 55th birthdays. But hold the cake. There’s not much to celebrate on this anniversary. You’d be hard pressed to find two more wasteful, fraud-ridden programs than Medicare and Medicaid. They grow less fiscally sustainable with each passing year. And they routinely deliver subpar care that, ...
Commentary

Affordable short-term healthcare plans can flourish thanks to Trump

Millions of people will continue to have access to affordable short-term health plans, thanks to a new ruling from the U.S. District Court of Appeals for the District of Columbia. A three-judge panel of the court upheld by a 2-1 margin a Trump administration rule extending the maximum duration of a short-term plan to ...
Commentary

After COVID-19 subsides, ‘the telehealth revolution must march on’

It’s hard to find a silver lining in a pandemic. But one of the few may be the rapid rise of telemedicine. With people stuck at home, doctors retooled their practices to see patients via videoconference. Insurance companies and regulators expanded the number of services available via telemedicine—and made reimbursement ...
Business & Economics

It’s time to bring our economy back to life. Paying workers to stay home won’t help

The federal government’s emergency unemployment benefits are set to expire this week. Set at $600 a week by the CARES Act — the economic rescue package Congress passed back in March — the emergency benefits were intended to supplement state unemployment insurance and offset the economic carnage caused by the coronavirus lockdowns. That extra ...
Commentary

Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs

President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Drug Pricing

Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing

Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Scroll to Top